Ready for Next-Gen Orthobiologics Tech?

Arthrex

Arthrex’s ACP Max Platelet-Rich Plasma (PRP) System provides efficient concentration of platelets and growth factors from PRP at the patient’s point of care. The sterile, triple-syringe system produces PRP with a high concentration of platelets and a depletion of neutrophils; activated platelets release proliferative and morphogenic proteins. Allows for a larger blood draw and is compatible with current ACP centrifuges. ACP Max provides:

• A fast, double-spin cycle that produces higher PRP volume and platelet concentrations from 30 mL, 60 mL, or 90 mL of whole blood.
  
• An up to 12 times increase over baseline platelet concentration, with greater than 97% reduction of neutrophils.

For more information, visit arthrex.com or click on "Learn More" below.